Inhibition of c-Met as Therapeutic Strategy for Papillary Thyroid Cancer

被引：0
|
作者：
Bu, Rong [1 ]
Hussain, Azhar [1 ]
Ahmed, Saeeda [1 ]
Uddin, Shahab [1 ]
Al-Kuraya, Khawla [1 ]
机构：
[1] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4671
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell invasion and its therapeutic inhibition with small interfering RNA specific for c-Met
    Leelawat, Kawin
    Leelawat, Surang
    Tepaksorn, Panada
    Rattanasinganchan, Panthip
    Leungchaweng, Anicha
    Tohtong, Rutaiwan
    Sobhon, Prasert
    JOURNAL OF SURGICAL RESEARCH, 2006, 136 (01) : 78 - 84
  • [32] Off-Target Effects of c-MET inhibitors on Thyroid Cancer Cells
    Zhou, Yan
    Zhao, Conghui
    Gery, Sigal
    Braunstein, Glenn D.
    Okamoto, Ryoko
    Alvarez, Rocio
    Miles, Steven A.
    Doan, Ngan B.
    Said, Jonathan W.
    Gu, Jiang
    Koeffler, H. Phillip
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (01) : 134 - 143
  • [33] c-Met: a New Cancer Stem Cell Marker and Therapeutic Target for Pancreatic Cancer
    Wu, J-J.
    Li, C.
    Hynes, M.
    Dosch, J.
    Sarkar, B.
    Magliano, M. P.
    Simeone, D. M.
    PANCREAS, 2011, 40 (08) : 1363 - 1363
  • [34] Upregulation of HGF and c-MET is Associated with Subclinical Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma
    Bon Seok Koo
    Jin Man Kim
    Sung Tae Seo
    Young Hoon Yoon
    Ki Ryun Kwon
    Sung Ha Kim
    Hye Won Kwon
    Won Jin Bae
    Young Chang Lim
    Annals of Surgical Oncology, 2014, 21 : 2310 - 2317
  • [35] Upregulation of HGF and c-MET is Associated with Subclinical Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma
    Koo, Bon Seok
    Kim, Jin Man
    Seo, Sung Tae
    Yoon, Young Hoon
    Kwon, Ki Ryun
    Kim, Sung Ha
    Kwon, Hye Won
    Bae, Won Jin
    Lim, Young Chang
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (07) : 2310 - 2317
  • [36] The role of c-Met inhibition for neuroblastoma treatment
    Zage, Peter
    Scorsone, Kathy
    Zhang, Linna
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] C-Met inhibition sensitivity in vitro: Autocrine vs. paracrine activation of the c-Met pathway
    Hughes, Veronica
    Siemann, Dietmar W.
    CANCER RESEARCH, 2015, 75
  • [38] Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition
    Maulik, G
    Shrikhande, A
    Kijima, T
    Ma, PC
    Morrison, PT
    Salgia, R
    CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (01) : 41 - 59
  • [39] Inhibition of c-met radio-sensitizes in breast cancer brain metastatic cancer
    Yang, Heekyoung
    Jin, Juyoun
    Kim, Misuk
    Kim, Kang Ho
    Kim, Donggeon
    Kang, Wonyoung
    Lee, Hyewon
    Joo, Kyeung Min
    Nam, Do-Hyun
    CANCER RESEARCH, 2012, 72
  • [40] Proteogenomics identifies c-Met inhibition as a therapeutic strategy for BAP1-deficient clear cell renal cell carcinoma
    Du, Bowen
    Zhou, Yulin
    Li, Wenzhi
    He, Haowei
    Chen, Ming
    Feng, Ninghan
    MOLECULAR BIOMEDICINE, 2024, 5 (01):
12345